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Abstract
For the past 40 years, practitioners and researchers alike have been grappling with the natural shortcomings 
associated with the net present value approach to strategic decision making and capital budgeting. Work by 
scholars in option pricing theory has evolved into an alternative perspective on strategic capital investments, 
called "real options." Proponents of real options argue that this is a superior way of approaching decision making 
and capital budgeting, compared with other approaches, as it allows for greater strategic flexibility and 
encourages exploration, experimentation, and innovation. Within the healthcare literature, articles on real 
options have focused on pricing these options. This article is unique to the healthcare literature as it emphasizes the 
cognitive or strategic aspects of real options. Additionally, this article integrates two techniques for applying the 
real options approach for interested practitioners using a hospital's imaging department as an example, while 
providing scholars with additional applications and questions for future research. For practitioners, the implications 
are that thinking of and planning for capital investments as real options may create greater strategic and 
operating flexibility than other, more traditional approaches.
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E X E C U T I V E S U M M A R Y
For the past 40 years, practitioners and researchers alike have been grappling with
the natural shortcomings associated with the net present value approach to strate-
gic decision making and capital budgeting. Work by scholars in option pricing
theory has evolved into an alternative perspeaive on strategic capital investments,
called "real options." Proponents of real options argue that this is a superior way
of approaching decision making and capital budgeting, compared with other ap-
proaches, as it allows for greater strategic flexibility and encourages exploration,
experimentation, and innovation. Within the healthcare literature, articles on real
options have focused on pricing these options.
This article is unique to the healthcare literature as it emphasizes the cognitive
or strategic aspects of real options. Additionally, this article integrates two tech-
niciues for applying the real options approach for interested practitioners using
a hospital's imaging department as an example, while providing scholars with
additional applications and questions for future research. Tor practitioners, the im-
plications are that thinking of and planning for capital investments as real options
may create greater strategic and operating flexibility than other, more traditional
approaches.
For more information on the concepts in this article, please contact
Dr, Williams at wil!imsdr@appstate.edu.
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A s tbe old adage says, "Patienceis a virtue." Within tbe past 30
years or so, strategic and financial
management scholars bave been
formulating a complementary set of
theories that incorporates this adage
as one of its core characteristics—the
option to delay or wait. Intuitively,
practitioners have known for some
time that delaying a project may
clarify uncertainty, thus reducing the
potential for a negative occurrence.
Take, for example, the situation where
a physician group asks a hospital to
acquire a new piece of technology
and expand its facilities at the same
time. The hospital administrator may
wish to maintain the right to delay the
more expensive project—expanding
its facility—until he knows that the
requesting physician group has first
used the piece of equipment to a
satisfactory level. This right or option
to delay has value. Thus, patience may
not only be a virtue, but it may also
have positive economic consequences
as v '̂ell.
Traditional capital budgeting
methods, such as the net present
value (NPV) approach, do not capture
this value to delay, however. Nor do
they capture other issues related
to operating fiexibility and strategic
interactions (Dixit 1989). In response
to this deficiency in strategic thinking
and capital budgeting techniques, a
growing body of literature has emerged
to help practitioners and researchers
deal with corporate decision making.
Scholars working in this field
call this body of literature "real
options." Real options are investment
opportunities that are characterized by
"a limited commitment that creates
future decision rights" (McGrath,
Ferrier, and Mendelow 2004, 86).
Thinking of capital budgeting decisions
as real options means thinking of
strategic and capital investments as
similar to financial stock options.
Proponents of real options suggest
that this form of strategic thinking
and investment is inherently more
beneficial than the NPV approach.
As Kogut and Kulatilaka {2001, 744)
observe, a "real options approach
marries the theory of financial options
to foundational ideas in strategy,
organizational theory, and complex
systems."
As illustrated, healthcare practition-
ers have likely been using this type of
logic for decades. ]ensen and Warren
(2001) note that the pharmaceutical
and biomedical industries are the
most frequently used examples in the
literature. However, our review of the
healthcare literature uncovered few
articles on real options. Literature
on real options can be divided into
its financial or pricing aspects and
its cognitive or strategic aspects. The
healthcare journal articles all deal with
the financial or pricing aspects. Thus,
after briefly describing the origins of
the concept of real options, we focus
on the cognitive or strategic aspects
and provide examples of strategic
applications within the healthcare
setting for both practitioners and
researchers.
O R I G I N S
Literature on real options emerged
from work by financial economists
who were developing an option pricing
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theory (e.g., Black and Scholes 1972,
1973; Merton 1973). These scholars
were seeking to create theories to
value financial option contracts. Before
this research on options, Miller and
Modigliani (MM) (1961) had shown
that a firm's market value represented
two parts: the present value of its
assets and the present value in its
grov*T;h opportunities in real assets.
Myers (1977) proposed thinking of
investment opportunities associated
with capital budgeting projects (i.e.,
the growth opportunities in real assets
as described in the MM model) as
growth options (Trigeorgis 1993).
As the literature developed, growth
options related to capital budgeting
decisions became known as options
in real assets or real options. Thus,
the literature related to option pricing
theory was expanded and applied to
capital budgeting issues.
An option is "a security giving the
right to buy or sell an asset, subject to
certain conditions, within a specified
period of time" (Black and Scholes
1972, 637). There are two main types
of option contracts: a call option and
a put option. A call option allows
the holder of the option the right to
purchase the underlying asset within
a given time and at a specified price
(known as the strike or exercise price).
A put option allows the holder of the
option to sell the underlying asset at
the strike price within the given period
of the contract. Combinations of put
and call options exist as well.
For example, when the hospital
mentioned previously purchases the
piece of equipment, it also acquires a
call option to expand its facilities, and
the option's exercise price is the cost
of expansion. In addition, the firm's
ability to sell that piece of equipment
(even at a loss) can be thought of as
a put option. The ability to delay a
projea is not the only area of flexibility
addressed within the literature on real
options. The major categories related
to real options include the option to
initiate, abandon, expand, contract,
wait, slow down, speed up, switch, sell,
or sequence a project (Bowman and
Hurry 1993; Merton 1998; Trigeorgis
1993). From the perspective of real
options, an explicit economic value
is associated with all of these areas of
flexibility.
Several different methods are used
to price real options. However, a review
of these methods is beyond the scope
of this article and is not necessary to
understand the logic and applications
of real options, which is the focus of
this article.'
R E A L O P T I O N S R E A S O N I N G
The cognitive aspects of the real
options literature are called "real
options reasoning" (e.g., McGrath
1996) or real options logic (e.g.,
McGrath 1997). McGrath, Ferrier,
and Mendelow (2004) note that real
options reasoning is often described as
a "process heuristic [that is, technique]
for understanding the economics
of sequential resource investment
choices." Thus, real options reasoning
"accommodates the value of flexibility,
differing resource allocation horizons,
the process of retrospective sense
making, and path dependence"
(McGrath and Nerkar 2004, 2).
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F I G U R E 1
Investment Approaches





(50% X ($8m - 5)) + (50% X (-$5m)) = -$1m
Real Options Reasoning Approach
Invest
$1.5m




Call Option to Invest In the
New Technology
Figure 1 provides a simplified
comparison in investment approaches
between real options and NPV
using our opening example.- In the
traditional approach, the hospital
administrator might contemplate a
$5 million investment in equipment
{costing $1 million) and facilities
(costing $4 million), with a 50 percent
prohahility of generating revenues
of $8 million and a 50 percent
probahility of losing the investment.
The option of delaying may also
have an additional cost of $500,000
for renovations to "house" the new
equipment temporarily. In the NPV
approach, the expected return is -$1
million, and the project will most
likely be rejected. Now consider the
options approach in which a smaller
amount, $1.5 million, is invested (for
equipment and renovations) until more
information on its usage is available. If
usage and information are positive, the
additional $4 million will be invested,
bringing the total investment to $5.5
million. This real options approach
generates an expected positive return of
$500,000. Hence, the two approaches
arrive at different conclusions.
It has been noted that the value of
flexibility (and thus the real options
approach) is greatest when uncertainty
is high and managers, through their
actions, have the opportunity to
affect the outcome or change course
(Copeland, Koller, and Murrin
2000; McGrath and Nerkar 2004).
To help think about this flexibility
systematically, we have expanded
and integrated two heuristics or
techniques embedded within the
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literature related to real options
reasoning, which may be useful to
strategic management scholars and
practitioners—those provided by Miller
and Waller (2003) and McGrath and
MacMillan (2000). For practitioners, we
suggest incorporating both techniques
into the strategic management process.
To our knowledge, no one has done
this. Thus, we propose that real options
reasoning be used in a systematic way
in addition to individual investment
decisions.
Practitioner Techniques
Miller and Waller (2003) suggest
ioining real options reasoning with
scenario planning. The strategic
management literature has long used
scenario planning as a tool to envision
plausible future states. At times,
scenario planning has quantitative
aspects, but more often, it is a
qualitative tool to help decision makers
generate options and contingencies.
Scenario planning also uses decision
trees at times. Both decision trees and
scenario planning have been used to
clarify uncertainty not only within
the real options literature, but also by
researchers and practitioners in fields
as far apart as strategic and quality
management.
We have modified and outlined
Miller and Waller's (2003) scenario
planning approach to real options.
These modifications include (1) ap-
plying it to a healthcare setting,
(2) reordering steps within their
process, (3) adding the plotting of
uncertainties via the use of McGrath
and MacMillan's (2000) technique,
and (4) suggesting that firms also
perform real options pricing during
this process. The purpose of scenario
planning in this context is to generate,
define, and systematize real options
and their risks. In this integrated
example, the application of McGrath
and MacMillan's (2000) technique is
embedded within the Miller and Waller
(2003) real options scenario-planning
approach. This approach is found in
Table 1 and Figure 2.
To explain this integrative ap-
proach, consider a hospital's itnaging
department. An imaging department is
one ofthe most capital-intense settings
within a hospital. It is also an area
that can help differentiate the hospital
or health system as a whole, such as
whether a hospital will be considered
"high-tech" or "high touch," Also,
many imaging department managers
have becorne more entrepreneurial in
their approach to capital investments,
and such investments are viewed
as strategic assets and part of joint
ventures, freestanding subsidiaries,
and the like. In this sense, rea! options
reasoning has also been suggested
to help entrepreneurs explore their
choices (McGrath 1999; Vassolo,
Anand, and Folta 2004).
Imaging department managers are
constantly exploring new technological
innovations and their applications.
However, the imaging department
manager faces limitations in terms
of competition within the hospital
for capital expenditures, market
or reimbursement uncertainties,
and technology uncertainties (i.e.,
what technology will become the
standard treatment protocol and/or
174




1.1. Frame the issue—what are the healthcare issues to be explored?
1.2. Identify participants and solicit input—who are the stakeholders (e.g., physicians,
insurance companies}?
1.2.1. Identify potential real options.
1.3. Identify exposures (see Table 2).




1.4. Plot market and technological uncertainties (see Figure 3).
1.5. Sketch out possible paths (e.g., decision trees)—what are the best- and worst-case
scenarios (possible paths); when/why should we abandon, delay, expand, etc.?
1.5.1. Test plausibility—do the envisioned paths logically follow what we now
know?
1.5.2. Perform real options pricing, preferably using decision trees.
1.6. Formulate strategies—based on the previous seven items, define initiatives.
2. Choose real options investments.
3. Implementation
3.1. Monitor key contingencies—at the corporate, business, and department levels.
3.2. Design flexibility into the process.
3.2.1. Organizational structures, management processes
3.2.2. Interfirm relationships with stakeholders
3.3. Reassess exposures and options.
3.4. Assess real options categories (e.g., delay, switch) via real options pricing decision
tree and possible paths.
is the technology as advanced "as the
salesperson tells us"). With respect to
market uncertainties, reimbursement
levels have a tendency to change over
time. Thus, a technology that is not
initially reimbursed may become
totally reimburseable as the technology
develops and becomes an accepted
practice. The reverse is also true.
The first major step after identifying
and framing the areas to be explored
is to identify and involve stakeholders.
For a hospital's imaging department,
these include, but are not limited to,
patients, radiologists, referring physi-
cians, nurses, radiology technicians,
payers, and suppliers. Stakeholders
will typically define the assumptions
related to the remaining steps within
the real options scenario planning.
They are also usually the first to suggest
which technologies or real options to
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—Indicates specific activities not found in Miller and Waller (20031
Double arrows indicate resulls from activity, rejoins the process ai that poini
pursue. (See "Stakeholder Impact" and
"Identify Potential Real Options" in
Figure 2.)
Management and stakeholders also
need to address internal and external
uncertainties. These involve issues
in the general and local economies,
hospital industry, and the hospital
and department specifically. (See
"Identify Exposures" in Figure 2.)
Table 2 provides examples of these
issues. Of particular importance
is the need to identify market and
technological uncertainties for capital
budget projects.
To help assess technological and
market uncertainties, McGrath and
MacMillan (2000) provide a second
technique. Much of the literature on
real options has to do with corporate
entrepreneurship (O'Brien, Folta, and
Johnson 2003). Williams, Duncan,
and Ginter (2005) have noted that
entrepreneurship is of increasing
importance to those in the healthcare
field. McGrath and MacMillan's
(2000) approach helps corporate
entrepreneurs decide which options
to pursue based on the option's
purpose and associated risks; corporate
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T A B L E 2
Exposures and Examples




















Technology " • '
Market
Disharmony, lack of cohesive policy
Increased regulation, cost-control pressures
Cost pressures, loss of employment due to outsourcing,
discontinuance of health insurance
Shift in social concern
Recent natural disasters affecting economic conditions
Physician shortages, specialty-driven
Beginnings of consumer-driven, price sensitive because of
managed care, quality difficult to measure, differentiation
primarily based on services
Local market dependent, introduction of substitutes (i,e.,
outpatient facilities)
Supply of labor (e,g., nurses), complexity
Malpractice
Limited
Slow accounts receivable because of payers
Difficulties associated with managing professionals (e.g.,
nurses, physicians)
Supply of labor {e.g., technicians)
Cost, short life cycle, compatibility, standard
Reimbursement
entrepreneurs usually pursue multiple
options simultaneously. The pursuit of
multiple options is known as creating
a portfolio of options (Bowman and
Hurry 1993).
McGrath and MacMillan (2000)
distinguish among three types of
options: positioning, scouting, and
stepping-stones. The distinctions
among these options are based on the
nature of the uncertaimy the corporate
entrepreneur faces—whether these are
market uncertainties or technological
uncertainties. Positioning options have
high technological uncertainty but low
market uncertainty. Scouting options
have low technological uncertainty
but high market uncertainty Stepping-
stone options have high market and
technological uncertainties.
Additionally, McGrath and
MacMillan (2000) note that firms
may also wish to make nonincremental
investments. These are called enhance-
ment launches and platform launches.
Enhancement and platform launches
do not require a limited commitment
that creates future decision rights.
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Enhancement launches are new
attributes for existing products, services,
or service lines. Platform launches are
new areas that allow one to offer new
products or services. The difference
between real options and launches is
that in launches one typically commits
to an up-front investment. In real
options (e.g., scouting), one makes an
incremental investment (i.e., acquires
an option) with the intent of exploring
and exercising the option (i.e., making
further investments) at a later date.
In terms of deciding how to use this
technique, McGrath and MacMillan
(2000, 180) observe that "the core
concept is to let your strategy and
available resources guide your choice of
how much emphasis to place on each
of the categories."
An example of an enhancement
launch is upgrading from a closed
magnetic resonance imaging (MRl)
machine that operates at 1.0 tesia
(magnet strength) to an open MRI that
operates at 1.5 tesla, provides better
picture quality and faster imaging, and
is generally perceived by the patient
as being less confining. An example
of a platform launch is "executive"
or "boutique" medicine. In this case,
the department acquires new, existing
technology to create a new service
or repackage services already offered,
and the value proposition is focused
on customer service (e.g., such as
access and/or convenience). It bundles
technology already offered (e.g.,
ultrasound, computed tomography
[CT| scan) into a new marketing effort
for the "worried well" (i.e., those
who can afford it and wish to get a
package of diagnostic screenings).
This executive medicine effort may
allow the hospital to launch into other
corporate medicine programs such as
occupational health. Enhancement
and platform launches both involve
capital expenditures that generally
are low with respect to market and
technological uncertainties (i.e., the
technology is known and accepted, and
there is generally a market for it).
Real options, on the other hand,
are associated with an element of
exploration—uncertainty is an inher-
ent quality (Bowman and Moskowitz
2001). In this respect, its proponents
argue, over time real options reason-
ing should improve institutional and
individual learning (McGrath, Ferrier,
and Mendelow 2004). An example of a
scouting option is virtual colonoscopy.
Here, the technology is known to
work; however, few payers currently
reimburse for this service, and it is
not known if or when the payers will
reimburse. We have a slightly different
case with our positioning option. Our
example is cardiac imaging. Here, we
have three competing technologies:
positron emission tomography (PET),
CT, and MRl. All three technologies
are known to work relatively well;
however, it is not known which tech-
nology will become the standard (and
thus the reimbursed technology). For
cardiology patients (typically the most
profitable patients for a hospital),
currently none of these technologies
are being reimbursed by most payers.
Finally, our example for stepping-stone
options is micro or nano body-imaging
technology. This technology is in the
developmental stage, and no payers
currently reimburse for its use. This
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technology, however, has tremendous
potential for those with vascular, car-
diothoradc, digestive, and respiratory
illnesses.
Within a portfolio of real options,
the imaging department manager must
decide where and how much to invest;
very few managers are ahle to acquire
all technoiogies. The NPV approach
would most likely suggest only the two
launches. This may be a good short-
term strategy, but the acquired technol-
ogy may be soon outdated and, thus,
competitive advantage will be lost.
The use of real options reasoning
allows the manager to use various
strategies to discern which technology
to pursue in the long term, with in-
cremental investments and alternative
financing arrangements facilitating the
real options approach. For example, the
manager may wish to use nonoption
thinking and acquire outright the en-
hancement and platform launches (e.g.,
open MRI, executive medicine). For
the hospital's cardiac imaging program,
it may wish to form a joint venture
with a company that provides mobile
PET, CY, and/or MRI units. Once the
standard (and thus reimbursement)
has been established, the program
managers can acquire the appropriate
technology, if they desire. For scouting
options, the hospital may wish to lease
with an option to buy the technology
associated with virtual colonoscopy
should the market uncertainty become
favorably clarified. In this example,
leasing the equipment is similar to
a call option written on a purchase
option. For a stepping-stone option,
the department can send its employees
to educational seminars (i.e., make a
minor investment); cosponsor research
and get more accurate information on
its technological progress; or become
an "alpha-site" cosponsor, whereby
research is performed on the hospital
campus but the hospital does not bear
the full cost of the new micro or nano
body-imaging technology. At any time
(and within the constraints of the
arrangements), the hospital can switch,
abandon, delay (or the like) any of the
options with less investment than it
otherwise may have incurred. Figure 3
plots these market and technological
uncertainties.
Once one has identified and as-
sessed the market and technological
uncertainties associated with a port-
folio of real options, one can discuss
the possible paths of each option. At
this juncture, managers discuss up front
with the stakeholders or select stake-
holders the assessment categories of
delaying, switching, abandoning (and
the like) for each investment decision.
This means consensus is sought for a
path for a given real option. In other
words, for a given real option if "x"
happens (such as a change in technol-
ogy or reimbursement), then our pos-
sible path is to "y" (e.g., delay, switch,
expand). This up-front discussion may
reduce uncertainty and friction later,
thus improving strategic flexibility,
which has value from a real options
perspective. At this point real options
pricing can be performed.
Based on the previous analysis,
an organization may wish to limit
the number or type of real options
to implement. (See "Choose Real
Options" in Figure 2.) Implement-
ing real options may involve new or
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Source: Adapted from McGrath and MacMillan (2000).
restructured organizational and man-
agement processes—all of which are
communicated with and/or derived
from the stakeholders. This action is
labeled as "Implement Real Options"
(Figure 2).
In addition to changing environ-
mental conditions, management's
action with respect to real options may
cause competitors and stakeholders
to respond. Thus, it may be necessary
to "Reassess Exposures and Options,"
which is performed in tandem with
"Assess Real Options Categories" (Fig-
ure 2). These assessment categories
mean the organization looks at the
real options and their possible paths
and decides whether to delay, abandon,
switch, speed up, and the like. During
this assessment, the organization may
also decide to re-perform real options
pricing for a given projea or projects.
Finally, the manager and a select
group of stakeholders may wish to
evaluate and modify this entire pro-
cess in the future. Miller and Waller
(2003) and others note that no process
or model fits all organizations and
industries exactly. We would add that
many of the steps outlined here are
iterative in nature, and there is much
going back and forth between the steps.
Admittedly, it should be noted
that real options reasoning and our
proposed process are not without their
own sets of issues and problems. These
include escalating commitment (e.g.,
Zardkoohi 2004), hysteresis (e.g., Dixit
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1989), and other psychological biases
(Adner and Levinthal 2004), Escalat-
ing commitment can occur when an
organization overcommits to a course
of action. Using the previous example,
in acquiring the piece of technology
the hospital administrator may have
"escalated" his commitment beyond
the objective facts of the situation and
may perceive an inability to not expand
the facility. Hysteresis is the inability to
reverse course when conditions change
imfavorably. For example, if equipment
usage was below expectations because
of a change in reimbursement, the
prudent thing may be for the hospital
to use its put option (i.e., sell the piece
of equipment, even at a loss). This
may not be possible because of other
faaors, such as physician preference.
S Y N O P S I S A N D R E S E A R C H
A P P L I C A T I O N S
Given the nascent nature of the liter-
ature on real options reasoning (Mc-
Grath, Ferrier, and Mendelow 2004)
and the uniqueness of the healthcare
sector, researchers may fitid it benefi-
cial to further explore this developing
theory. Following is a synopsis of the
literature on real options and areas of
potential inquiry for researchers.
Table 3 presents a list of various
studies within the real options reason-
ing literature. These articles were iden-
tified by a four-step approach. First, we
conducted a search using the term "real
options" within the abstract section
of articles and within the CINAHL,
EBSCOHOST, and JSTOR databases.
Next, we did specific searches within
the healthcare journals that were in-
cluded in the journal rankings' study
conducted by Williams and colleagues
(2002). Of note, we found no health-
care journal articles that dealt primarily
with real options reasoning. Third, we
performed specific searches of journals
included in the most influential man-
agement journals, as reported by Tahai
and Meyer (1999), and the top-tier
entrepreneurship journals, as reported
by Boals (2006). Finally, because much
of the literature on real options pricing
has an inherent reai options reasoning
aspect, we reviewed much of the ac-
counting, finance, and economic liter-
ature related to real options. However,
we found only one article specifically
focusing on real options reasoning.
From this review, four broad
themes stand out. First, it is apparent
that the boundaries in this literature
have not been clearly delineated, as a
series of articles published in the Jan-
uary 2004 issue of The Academy of Man-
agement Review suggests. Second, we
do not know much about real options
reasoning usage, especially by health-
care practitioners. In other words, we
do not know which organizations are
using real options reasoning, or how
and why they are using it. Third, and
similar to Folta and O'Brien (2004),
we found that most of the literature
was metaphorical; our review found
only two empirical articles related
to real options reasoning and the
healthcare sector. Vassolo, Anand, and
Folta (2004) examined pharmaceutical
and biotechnology companies, and
McGrath and Nerkar (2004) examined
pharmaceutical companies. Finally, the
literature on real options reasoning
has not tested whether the use of real
options reasoning has increased firm
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Warner, Fairbank, and Reasoning
Steensma (200f.)
Acquisition
Supports concept of joint ventures as real
options to expand given technological and
market uncertainties
Shows differences between Japanese and U,S,
venture capitalist use of real options
Iniroduces shadow options and option chains
future organizational capabilities
Shows entrepreneurs using social capital to
create option chains
Links technology options with other (broader)
environmental issues
Uses real options reasoning to describe failure
by entrepreneurial firms
Illustrates practical difficulty in using analysis
Shows that real options as an appropriate
theoretical foundation for heuristic frames relate
to exploration and value capabilities
Links pharmaceutical companies' aaivities with
real options reasoning to reduce uncertainty
Links real options to scenario planning
Empirically tests usage of real options reasoning
by entrepreneurs and finds ihat high uncertainty
dissuades entry into new venture
Illustrates that the less structured a firm's
abandonment criteria, the less like they are to
tie real options
Demonstrates that ihe relationship between
uncertainty and entry is not monotonic
A response to Adner and Levinthal (2004)
Compares real options pricing to evolutionary
and real options reasoning
Finds thai decision makers either explicitly or
implicitly use real options reasoning
Illustrates interactions by exploratory
investments both within and between portfolios
Shows that firm rules, criteria, procedures,
and other theories usually limit escalation of
commitment issues
Shows early acquisition as a growth option
" Studies are ordered by date.
^ The research applies equally to both real options reasoning and pricing.
* Healthcare related (pharmaceutical and/or biotechnology).
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performance or led to competitive
advantage. Research in these areas
would add to the literature on both
healthcare and real options reasoning
and, perhaps, provide greater guidance
to healthcare organizations in their use.
To assist with this work, we offer
Table 4, which provides healthcare
examples of potential real options.
The examples in Table 4 can be used
to address any of the issues identified
in the broad themes or the following
research questions. Table 4 uses Burns's
(2002, 2005) expanded view of the
U.S. healthcare value chain. 'iTie value
chain components include purchasers,
fiscal intermediaries, providers, product
intermediaries, and producers. We
use one area (e.g., insurers, hospitals)
within these components (e.g., pur-
chasers, fiscal intermediaries) and the
major categories (e.g., delay, switch)
described in the literature on real op-
tions to highlight how prartitioners
may use real options reasoning, and
where researchers may find it profitable
to spend their future efforts.
From Table 4, several questions
come to mind;
• How do healthcare-specific regula-
tions and laws (e.g., Stark, inure-
ment, certificate of need) moderate
or mediate real options approaches?
• Do healthcare organizations system-
atize real options approaches (i.e., do
they incorporate it into their strategic
planning process)?
• Do some areas along the value chain
use real options approaches more
or less than other areas on the value
chain? Why?
• How does one party's (e.g., em-
ployer) real options approach affect
another party's (e.g., insurer) real
options approaches?
• Are healthcare providers (e.g., hos-
pitals) less likely to "abandon" an
initiative than other nonhealthcare
industries because of their nature
(i.e., service) and visibility? (That is,
can a hospital abandon an expan-
sion of its facilities in the middle of
construaion to the same extent as a
manufacturing plant?)
• Has the real options approach led to
greater profitability for the adopting
healthcare firm?
• Have real options approaches led
to more or less diversification in
healthcare?
• How can real options approaches be
adopted to encourage greater health-
care corporate entrepreneurship?
• Does an industry life cycle affect real
options approaches?
C O N C L U S I O N
This article highlights the literature
on real options reasoning. We pro-
vide applications for practitioners and
healthcare researchers alike, noting that
the literature remains pre-paradigmatic
and in need of further research. We
believe this is the first article to suggest
that practitioners may wish to consider
using the two real options reasoning
techniques as part of their strategic
management process.
We realize practitioners may have
been using real options reasoning
for some time. Yet we also believe
they may have been troubled when
they sought to express and reconcile
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• Not traditionally thought ol" as a lapiial expetise, bui Dixit and Pindyck (1994) note that real options can be
applied to other situations involving uncertainty, risk, and sunk costs.
' GPO = group purchasing oi^anization; ' PBM = pharmacy benefits management company; * PPO = preferred
provider organization, HMO = health maintenance organizaiion; ' MSA = medical savings account; " NICU =
neonatal intensive care unit.
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their logic related to capital budgeting
atid the NPV approach. We offer this
article as a starting point toward a
better understanding of these issues.
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